Ourobionics launches CHIMERA at the ScSB Meeting
OUR TECHNOLOGY
​ADVANCEMENTS IN BIOTECHNOLOGY.
3D Biofabricated tissues with and without embedded biosensors, bioelectronics, and novel therapeutic agents have the potential to make a huge impact on the current possibilities within regenerative medicine and to address a wide range of challenges within healthcare.
The Ourobionics company vision is to combine advanced 3D biofabrication and cyborganic technologies in order to develop these revolutionary, next generation solutions in the field of regenerative medicine for the diagnosing, monitoring, and treatment of diseases or repair of dysfunctional tissues. In addition to this long-term vision of merging regenerative medicine and human-machine interfaces our products and services will indirectly contribute to a second challenge which is the global need to reduce of animal testing. By focusing on advanced 3D biofabrication and cyborganics we will have the ability to develop of high throughput tissue structures and sensor technology, revolutionizing the drug testing industry.
OUR ARTICLES
OUROBIONICS
LATEST ARTICLES
Ourobonics was incorporated in 2021 by a team of business & industry experts along with a team of academic experts. Follow us through our journey to end animal testing